2-methyl-3-(4-phenylpiperidino)propionohydroxamic acid hydrochloride has been researched along with bis(5-amidino-2-benzimidazolyl)methane in 1 studies
*bis(5-amidino-2-benzimidazolyl)methane: aromatic diamidine which has a significant suppressive effect on the cytopathology & yield of respiratory synctial (RS) virus; RN given refers to parent cpd [MeSH]
*bis(5-amidino-2-benzimidazolyl)methane: aromatic diamidine which has a significant suppressive effect on the cytopathology & yield of respiratory synctial (RS) virus; RN given refers to parent cpd [MeSH]
| Studies (2-methyl-3-(4-phenylpiperidino)propionohydroxamic acid hydrochloride) | Trials (2-methyl-3-(4-phenylpiperidino)propionohydroxamic acid hydrochloride) | Recent Studies (post-2010) (2-methyl-3-(4-phenylpiperidino)propionohydroxamic acid hydrochloride) | Studies (bis(5-amidino-2-benzimidazolyl)methane) | Trials (bis(5-amidino-2-benzimidazolyl)methane) | Recent Studies (post-2010) (bis(5-amidino-2-benzimidazolyl)methane) |
|---|---|---|---|---|---|
| 10 | 0 | 0 | 30 | 0 | 1 |
| Protein | Taxonomy | 2-methyl-3-(4-phenylpiperidino)propionohydroxamic acid hydrochloride (IC50) | bis(5-amidino-2-benzimidazolyl)methane (IC50) |
|---|---|---|---|
| Coagulation factor X | Homo sapiens (human) | 4.5 | |
| Trypsin-1 | Homo sapiens (human) | 4.4 | |
| Trypsin-2 | Homo sapiens (human) | 4.4 | |
| Trypsin-3 | Homo sapiens (human) | 4.4 | |
| Tryptase alpha/beta-1 | Homo sapiens (human) | 0.051 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bing, DH; Falk, RJ; Geratz, JD; Jennette, JC; Tidwell, RR | 1 |
1 other study(ies) available for 2-methyl-3-(4-phenylpiperidino)propionohydroxamic acid hydrochloride and bis(5-amidino-2-benzimidazolyl)methane
| Article | Year |
|---|---|
Amelioration of immune complex-mediated glomerulonephritis by synthetic protease inhibitors.
Topics: Amidines; Animals; Benzimidazoles; Complement Inactivator Proteins; Creatinine; Glomerulonephritis; Hydroxamic Acids; Immune Complex Diseases; Indoles; Male; Mice; Protease Inhibitors; Time Factors; Trypsin Inhibitors | 1987 |